A new trading day began on Tuesday, with Olema Pharmaceuticals Inc (NASDAQ: OLMA) stock price down -9.28% from the previous day of trading, before settling in for the closing price of $12.72. OLMA’s price has ranged from $8.51 to $17.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -6.23%. With a float of $49.24 million, this company’s outstanding shares have now reached $54.99 million.
The extent of productivity of a business whose workforce counts for 74 workers is very important to gauge. In terms of profitability, gross margin is 80.89%, operating margin of -6455.79%, and the pretax margin is -5818.79%.
Olema Pharmaceuticals Inc (OLMA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 14.02%, while institutional ownership is 87.88%. The most recent insider transaction that took place on Aug 01 ’24, was worth 35,796,000. In this transaction 10% Owner of this company sold 2,400,000 shares at a rate of $14.91, taking the stock ownership to the 783,118 shares. Before that another transaction happened on Jul 29 ’24, when Company’s Director sold 4,066 for $15.58, making the entire transaction worth $63,348. This insider now owns 752,217 shares in total.
Olema Pharmaceuticals Inc (OLMA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -6.23% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Here are Olema Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.06, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.61 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
The latest stats from [Olema Pharmaceuticals Inc, OLMA] show that its last 5-days average volume of 0.51 million was inferior to 0.74 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.63%. Additionally, its Average True Range was 0.68.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 21.48%, which indicates a significant increase from 15.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.73% in the past 14 days, which was lower than the 61.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.08, while its 200-day Moving Average is $12.17. Now, the first resistance to watch is $12.39. This is followed by the second major resistance level at $13.25. The third major resistance level sits at $13.71. If the price goes on to break the first support level at $11.07, it is likely to go to the next support level at $10.61. Assuming the price breaks the second support level, the third support level stands at $9.75.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
With a market capitalization of 660.86 million, the company has a total of 57,266K Shares Outstanding. Currently, annual sales are 0 K while annual income is -96,660 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,380 K.
